» Articles » PMID: 10973216

Tissue-engineered Bone Regeneration

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2000 Sep 6
PMID 10973216
Citations 303
Authors
Affiliations
Soon will be listed here.
Abstract

Bone lesions above a critical size become scarred rather than regenerated, leading to nonunion. We have attempted to obtain a greater degree of regeneration by using a resorbable scaffold with regeneration-competent cells to recreate an embryonic environment in injured adult tissues, and thus improve clinical outcome. We have used a combination of a coral scaffold with in vitro-expanded marrow stromal cells (MSC) to increase osteogenesis more than that obtained with the scaffold alone or the scaffold plus fresh bone marrow. The efficiency of the various combinations was assessed in a large segmental defect model in sheep. The tissue-engineered artificial bone underwent morphogenesis leading to complete recorticalization and the formation of a medullary canal with mature lamellar cortical bone in the most favorable cases. Clinical union never occurred when the defects were left empty or filled with the scaffold alone. In contrast, clinical union was obtained in three out of seven operated limbs when the defects were filled with the tissue-engineered bone.

Citing Articles

Bolstered bone regeneration by multiscale customized magnesium scaffolds with hierarchical structures and tempered degradation.

Lv Z, Peng B, Ye Y, Xu H, Cai X, Liu J Bioact Mater. 2025; 46():457-475.

PMID: 39850024 PMC: 11755084. DOI: 10.1016/j.bioactmat.2024.12.002.


Hydrogel microspheres for bone regeneration through regulation of the regenerative microenvironment.

Zhang P, Qin Q, Cao X, Xiang H, Feng D, Wusiman D Biomater Transl. 2024; 5(3):205-235.

PMID: 39734698 PMC: 11681181. DOI: 10.12336/biomatertransl.2024.03.002.


Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.

Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C Biomaterials. 2024; 315:122916.

PMID: 39490060 PMC: 11658005. DOI: 10.1016/j.biomaterials.2024.122916.


Anti-aging Metabolite-Based Polymeric Microparticles for Intracellular Drug Delivery and Bone Regeneration.

Wang Z, Hu J, Marschall J, Yang L, Zeng E, Zhang S Small Sci. 2024; 4(10).

PMID: 39386061 PMC: 11460827. DOI: 10.1002/smsc.202400201.


Mesenchymal Stem Cells in Myelodysplastic Syndromes and Leukaemia.

Eroz I, Kakkar P, Lazar R, El-Jawhari J Biomedicines. 2024; 12(8).

PMID: 39200142 PMC: 11351218. DOI: 10.3390/biomedicines12081677.